Blankenburg Thomas, Guettel Anne, Busch Christian, Schuette Wolfgang
Second Medical Clinic, Hospital Martha-Maria Halle-Doelau, Halle, Germany.
Clin Respir J. 2013 Jul;7(3):261-7. doi: 10.1111/j.1752-699X.2012.00314.x. Epub 2012 Aug 24.
While the severity of stable chronic obstructive pulmonary disease (COPD) has been defined in a valid and relevant prognostic manner, parameters that describe the course of COPD exacerbations are not yet established. Physical performance and dyspnoea are of prognostic relevance in stable COPD. The issue investigated was to assess the course of COPD exacerbations to find parameters that describe this situation better.
In 82 hospitalised patients with acute exacerbation of COPD who responded to intensified medical treatment (age 67.3 ± 9.5 years; forced expiratory volume in 1 s 1.0l, 40% predicted), we measured the 6-min walk distance and the visual analogue scale dyspnoea scores before the start of treatment, prior to discharge and after a 4-week stable period. Additionally, the conventional clinical parameters of COPD and quality of life were documented.
The 6-min walk distance was significantly increased from 97 ± 114 m to 290 ± 106 m. After 4 weeks of outpatient treatment in clinically stable patients, the 6-min walk distance fell non-significantly to 270 ± 120 m. The increment in walk distance fell significantly with advancing severity of COPD: from 112 ± 68 m for grade I and II to 56 ± 88 m for grade IV. Resting as well as exertional dyspnoea scores were significantly reduced (resting dyspnoea from 4 to 2 and exertional dyspnoea from 8 to 6).
We were able to demonstrate that 6-min walk test and dyspnoea scores, but not pulmonary function test, are suitable parameters to assess the course of COPD exacerbations.
虽然稳定期慢性阻塞性肺疾病(COPD)的严重程度已通过有效且相关的预后方式进行了定义,但描述COPD急性加重病程的参数尚未确立。身体活动能力和呼吸困难在稳定期COPD中具有预后相关性。本研究探讨的问题是评估COPD急性加重的病程,以找到能更好描述这种情况的参数。
我们对82例因COPD急性加重住院且对强化治疗有反应的患者(年龄67.3±9.5岁;第1秒用力呼气容积为1.0l,占预计值的40%),在治疗开始前、出院前以及4周稳定期后测量了6分钟步行距离和视觉模拟评分法的呼吸困难评分。此外,还记录了COPD的传统临床参数和生活质量。
6分钟步行距离从97±114米显著增加至290±106米。在临床稳定的患者进行4周门诊治疗后,6分钟步行距离无显著下降,降至270±120米。随着COPD严重程度的增加,步行距离的增加显著下降:从Ⅰ级和Ⅱ级的112±68米降至Ⅳ级的56±88米。静息及运动时的呼吸困难评分均显著降低(静息呼吸困难评分从4分降至2分,运动时呼吸困难评分从8分降至6分)。
我们能够证明,6分钟步行试验和呼吸困难评分是评估COPD急性加重病程的合适参数,而肺功能测试并非如此。